Based at UC San Diego, ADCS is an NIH-funded national consortium of Alzheimer's disease researchers conducting AD clinical trials throughout U.S. and Canada.
Raising Thiamine Levels in the Brain to Treat Early Alzheimer’s Disease Dr. Jose Luchsinger Benfo Team on the Empowered Patient Podcast with Karen Jagoda
https://t.co/EIOhNlLy2H
Peter Lucchini was diagnosed w/ early-onset #Alzheimer’s & began receiving care from Gabriel Leger, MD, #UCSDHealth. Both recently spoke with NBC’s @mariashriver on @TODAYshow where they shared his journey & the early warning signs of #AlzheimersDisease. https://t.co/AbxQzrgKMA
UC San Diego neurologist Dr. Gabriel Leger talks on The Today Show about early warning signs of Alzheimer's Disease, saying that onset can be pushed back or delayed. https://t.co/80k7fqI0Od #Alzheimers#neurology#health#brainhealth#ucsandiego#todayshow
We invite you to join the Shiley-Marcos Alzheimer’s Disease Research Center for the Shiley Endowed Lecture on February 1st at 9 am, in ACTRI Auditorium. More information in flyer below and please RSVP here: https://t.co/upNeXB6Xiu
Come to San Diego! To lead our nationally recognized aging institute! See link here - deadline for applications is June 15, 2023. Reach out with any questions and RT! https://t.co/vZ1HXi0zu1
Objective sleep variability from accelerometry, amyloid PET burden, and cognition, a new pub by Laura Fenton @laurafenton91 and via the committed data collection of many! https://t.co/3xBaFXdCHf
Latest from the lab: we used the polygenic hazard score to model a way to recruit efficiently for AD trials 🧠🧬🥼with tau or cog outcomes, led by Xin Wang: https://t.co/m1Izk6umav
Clinical neuropsychology postdoc available in Alzheimer’s/imaging/sex diffs/modifiable risk details here: https://t.co/b9WpK5fTps feel free to email and please retweet! Pic 10 mins from the office! 🧠🧠🧠🐬
Positive study results in the Alzheimer's drug lecanemab were released this week. Dr. Judy Pa, Co-Director of the Alzheimer's Disease Cooperative Study @PaLab_UCSD , spoke to KNX about what the results mean for Alzheimer's research. https://t.co/jG08NUH2Qk #Alzheimers#lecanemab